A recent Journal of Drugs in Dermatology study about a micropeptide with anti-aging and anti-inflammatory effects made news in Dermatology Times. The study, “Acetyl Dipeptide-31 Amide: A Novel Cosmetic Anti-Inflammatory…
Read More
JDD Spotlight: Guselkumab's 5-Year Promise in Psoriasis Curious about long-term breakthroughs in psoriasis care? A recent pooled analysis from the Phase 3 VOYAGE studies hints that guselkumab might be a…
Read More
Check out our all-new JDD Video Abstract from Naiem T. Issa, MD, PhD, who discusses how new formulations of acyclothymidine dinucleosides reduces the damaging effects of ultraviolet radiation in an…
Read More
Dupilumab Treatment Improves Lichenification in Atopic Dermatitis in Different Age and Racial Groups
JDD Spotlight: Dupilumab Shows Rapid, Sustained Relief for Lichenification in AD A new pooled analysis from five clinical trials has revealed that dupilumab significantly improves lichenification in moderate to severe…
Read More
JDD Spotlight The PROAK study evaluated real-world outcomes in patients with actinic keratosis reated with tirbanibulin 1% ointment over 24 weeks. Early improvements in quality of life were noted as…
Read More
From the Vault Do collagen supplements really work for skin? Collagen supplements are booming in the skincare world, but do they truly deliver on their promises? With little regulation around…
Read More
PSO Exciting: Clinical Pearls and Emerging Therapies For Psoriasis The field of dermatology continues to evolve at a rapid pace, bringing groundbreaking research from the lab to the clinic. As…
Read More
Trending Article Alert Integrated skincare—the future of aesthetic outcomes? A roundtable, featured at the Thriving in Diversity webinar series, brought together leading dermatologists and cosmetic surgeons to discuss how integrated…
Read More
Did You Miss It? How does the roflumilast cream vehicle compare? For patients with inflammatory dermatologic conditions, a hydrating vehicle is key to improving the skin barrier without irritation. But…
Read More
From the Vault Isotretinoin remains the gold standard for treating severe nodulocystic acne, yet concerns about its potential psychiatric effects continue to spark debate. While high-quality studies have found no…
Read More
Featured Podcast Managing alopecia is already anxiety provoking enough, but throw some inflammatory scalp diseases into the mix...ok deep breaths...think of a happy place. So happy your brain brought you…
Read More
Featured Article Acanthosis nigricans disproportionately affects individuals with darker skin tones, yet no FDA-approved treatment currently exists. As the demand for effective therapies grows, the dermatology community faces a critical challenge:…
Read More
